Intuitive Surgical, Inc. Sales-type Lease, Lease Income
Intuitive Surgical, Inc. (ISRG) reported Sales-type Lease, Lease Income of $20.80 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-21.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SalesTypeLeaseLeaseIncome · last filed 2026-07-21
- Intuitive Surgical, Inc. sales-type lease, lease income for the quarter ending 2026-06-30 was $20.80M, a 37.75% increase year-over-year.
- Intuitive Surgical, Inc. sales-type lease, lease income for the quarter ending 2026-03-31 was $32.70M, a 23.40% increase year-over-year.
- Intuitive Surgical, Inc. sales-type lease, lease income for the quarter ending 2025-12-31 was $24.80M, a 66.71% decline year-over-year.
- Intuitive Surgical, Inc. sales-type lease, lease income for the quarter ending 2025-09-30 was $30.90M, a 2.32% increase year-over-year.
- Intuitive Surgical, Inc. sales-type lease, lease income for fiscal 2025 was $97.30M, a 40.34% decline from fiscal 2024.
- Intuitive Surgical, Inc. sales-type lease, lease income for fiscal 2024 was $163.10M, a 108.04% increase from fiscal 2023.
- Intuitive Surgical, Inc. sales-type lease, lease income for fiscal 2023 was $78.40M, a 49.87% decline from fiscal 2022.
- Intuitive Surgical, Inc. sales-type lease, lease income for fiscal 2022 was $156.40M, a 29.01% decline from fiscal 2021.
| Period end | Sales-type Lease, Lease Income 3 month | Sales-type Lease, Lease Income 3 month as first filed | Sales-type Lease, Lease Income 6 month | Sales-type Lease, Lease Income 9 month | Sales-type Lease, Lease Income 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $20.80M 10-Q · filed 2026-07-21 | $53.50M 10-Q · filed 2026-07-21 | $78.30M derived: sum of 3 quarters · filed 2026-07-21 | $109.20M derived: sum of 4 quarters · filed 2026-07-21 | |
| 2026-03-31 | $32.70M 10-Q · filed 2026-04-22 | $57.50M derived: sum of 2 quarters · filed 2026-04-22 | $88.40M derived: sum of 3 quarters · filed 2026-04-22 | $103.50M derived: sum of 4 quarters · filed 2026-07-21 | |
| 2025-12-31 | $24.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-03 | $55.70M derived: sum of 2 quarters · filed 2026-02-03 | $70.80M derived: sum of 3 quarters · filed 2026-07-21 | $97.30M 10-K · filed 2026-02-03 | |
| 2025-09-30 | $30.90M 10-Q · filed 2025-10-22 | $46.00M derived: sum of 2 quarters · filed 2026-07-21 | $72.50M 10-Q · filed 2025-10-22 | $147.00M derived: sum of 4 quarters · filed 2026-07-21 | |
| 2025-06-30 | $15.10M 10-Q · filed 2026-07-21 | $41.60M 10-Q · filed 2026-07-21 | $116.10M derived: sum of 3 quarters · filed 2026-07-21 | $146.30M derived: sum of 4 quarters · filed 2026-07-21 | |
| 2025-03-31 | $26.50M 10-Q · filed 2026-04-22 | $101.00M derived: sum of 2 quarters · filed 2026-04-22 | $131.20M derived: sum of 3 quarters · filed 2026-04-22 | $176.30M derived: sum of 4 quarters · filed 2026-04-22 | |
| 2024-12-31 | $74.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-03 | $104.70M derived: sum of 2 quarters · filed 2026-02-03 | $149.80M derived: sum of 3 quarters · filed 2026-02-03 | $163.10M 10-K · filed 2026-02-03 | |
| 2024-09-30 | $30.20M 10-Q · filed 2025-10-22 | $75.30M derived: sum of 2 quarters · filed 2025-10-22 | $88.60M 10-Q · filed 2025-10-22 | $112.50M derived: sum of 4 quarters · filed 2026-02-03 | |
| 2024-06-30 | $45.10M 10-Q · filed 2025-07-23 | $58.40M 10-Q · filed 2025-07-23 | $82.30M derived: sum of 3 quarters · filed 2026-02-03 | $101.50M derived: sum of 4 quarters · filed 2026-02-03 | |
| 2024-03-31 | $13.30M 10-Q · filed 2025-04-23 | $37.20M derived: sum of 2 quarters · filed 2026-02-03 | $56.40M derived: sum of 3 quarters · filed 2026-02-03 | $68.70M derived: sum of 4 quarters · filed 2026-02-03 | |
| 2023-12-31 | $23.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-03 | $43.10M derived: sum of 2 quarters · filed 2026-02-03 | $55.40M derived: sum of 3 quarters · filed 2026-02-03 | $78.40M 10-K · filed 2026-02-03 | |
| 2023-09-30 | $19.20M 10-Q · filed 2024-10-18 | $31.50M derived: sum of 2 quarters · filed 2024-10-18 | $54.50M 10-Q · filed 2024-10-18 | $95.60M derived: sum of 4 quarters · filed 2025-01-31 | |
| 2023-06-30 | $12.30M 10-Q · filed 2024-07-19 | $35.30M 10-Q · filed 2024-07-19 | $76.40M derived: sum of 3 quarters · filed 2025-01-31 | $106.00M derived: sum of 4 quarters · filed 2025-01-31 | |
| 2023-03-31 | $23.00M 10-Q · filed 2024-04-19 | $64.10M derived: sum of 2 quarters · filed 2025-01-31 | $93.70M derived: sum of 3 quarters · filed 2025-01-31 | $143.80M derived: sum of 4 quarters · filed 2025-01-31 | |
| 2022-12-31 | $41.10M derived: 10-K 12 month − 10-Q 9 month · filed 2025-01-31 | $70.70M derived: sum of 2 quarters · filed 2025-01-31 | $120.80M derived: sum of 3 quarters · filed 2025-01-31 | $156.40M 10-K · filed 2025-01-31 | |
| 2022-09-30 | $29.60M 10-Q · filed 2023-10-20 | $79.70M derived: sum of 2 quarters · filed 2023-10-20 | $115.30M 10-Q · filed 2023-10-20 | $195.30M derived: sum of 4 quarters · filed 2024-01-31 | |
| 2022-06-30 | $50.10M 10-Q · filed 2023-07-24 | $85.70M 10-Q · filed 2023-07-24 | $165.70M derived: sum of 3 quarters · filed 2024-01-31 | $204.70M derived: sum of 4 quarters · filed 2024-01-31 | |
| 2022-03-31 | $35.60M 10-Q · filed 2023-04-20 | $115.60M derived: sum of 2 quarters · filed 2024-01-31 | $154.60M derived: sum of 3 quarters · filed 2024-01-31 | $238.60M derived: sum of 4 quarters · filed 2024-01-31 | |
| 2021-12-31 | $80.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-01-31 | $119.00M derived: sum of 2 quarters · filed 2024-01-31 | $203.00M derived: sum of 3 quarters · filed 2024-01-31 | $220.30M 10-K · filed 2024-01-31 | |
| 2021-09-30 | $39.00M 10-Q · filed 2022-10-21 | $123.00M derived: sum of 2 quarters · filed 2022-10-21 | $140.30M 10-Q · filed 2022-10-21 | $198.20M derived: sum of 4 quarters · filed 2023-02-10 | |
| 2021-06-30 | $84.00M 10-Q · filed 2022-07-22 | $101.30M 10-Q · filed 2022-07-22 | $159.20M derived: sum of 3 quarters · filed 2023-02-10 | $183.90M derived: sum of 4 quarters · filed 2023-02-10 | |
| 2021-03-31 | $17.30M 10-Q · filed 2022-04-22 | $75.20M derived: sum of 2 quarters · filed 2023-02-10 | $99.90M derived: sum of 3 quarters · filed 2023-02-10 | $116.70M derived: sum of 4 quarters · filed 2023-02-10 | |
| 2020-12-31 | $57.90M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-10 | $82.60M derived: sum of 2 quarters · filed 2023-02-10 | $99.40M derived: sum of 3 quarters · filed 2023-02-10 | $154.40M 10-K · filed 2023-02-10 | |
| 2020-09-30 | $24.70M 10-Q · filed 2021-10-20 | $41.50M derived: sum of 2 quarters · filed 2021-10-20 | $96.50M 10-Q · filed 2021-10-20 | $143.40M derived: sum of 4 quarters · filed 2022-02-03 | |
| 2020-06-30 | $16.80M 10-Q · filed 2021-07-21 | $71.80M 10-Q · filed 2021-07-21 | $118.70M derived: sum of 3 quarters · filed 2022-02-03 | $133.50M derived: sum of 4 quarters · filed 2022-02-03 | |
| 2020-03-31 | $55.00M 10-Q · filed 2021-04-21 | $101.90M derived: sum of 2 quarters · filed 2022-02-03 | $116.70M derived: sum of 3 quarters · filed 2022-02-03 | $132.00M derived: sum of 4 quarters · filed 2022-02-03 | |
| 2019-12-31 | $46.90M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-03 | $61.70M derived: sum of 2 quarters · filed 2022-02-03 | $77.00M derived: sum of 3 quarters · filed 2022-02-03 | $81.60M 10-K · filed 2022-02-03 | |
| 2019-09-30 | $14.80M 10-Q · filed 2020-10-19 | $30.10M derived: sum of 2 quarters · filed 2020-10-19 | $34.70M 10-Q · filed 2020-10-19 | $56.20M derived: sum of 4 quarters · filed 2021-02-10 | |
| 2019-06-30 | $15.30M 10-Q · filed 2020-07-23 | $19.90M 10-Q · filed 2020-07-23 | $41.40M derived: sum of 3 quarters · filed 2021-02-10 | $64.40M derived: sum of 4 quarters · filed 2021-02-10 | |
| 2019-03-31 | $4.60M 10-Q · filed 2020-04-17 | $20.40M 10-Q · filed 2019-04-19 | $26.10M derived: sum of 2 quarters · filed 2021-02-10 | $49.10M derived: sum of 3 quarters · filed 2021-02-10 | $62.40M derived: sum of 4 quarters · filed 2021-02-10 |
| 2018-12-31 | $21.50M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-10 | $44.50M derived: sum of 2 quarters · filed 2021-02-10 | $57.80M derived: sum of 3 quarters · filed 2021-02-10 | $69.80M 10-K · filed 2021-02-10 | |
| 2018-09-30 | $23.00M 10-Q · filed 2019-10-18 | $36.30M derived: sum of 2 quarters · filed 2019-10-18 | $48.30M 10-Q · filed 2019-10-18 | ||
| 2018-06-30 | $13.30M 10-Q · filed 2019-07-22 | $25.30M 10-Q · filed 2019-07-22 | |||
| 2018-03-31 | $9.50M 10-Q · filed 2019-04-19 | ||||
| 2017-12-31 | $49.50M 10-K · filed 2020-02-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Edwards Lifesciences Corp (EW) | United States | $49.409B | 51.96 |
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |